Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
Clinical trial NCT05222529 · RECRUITING
Trial details
- NCT number
- NCT05222529
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-29
- Primary completion
- 2027-07-30
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.